| Date | Name | Title | Type | Shares Traded | Price Range | |||
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2008 | kolinski stuart | Officer | Option Execute | 9,992 | 8.50 | |||
| Sep 16, 2008 | roberts william | Officer | Disposition (Non Open Market) | 15,308 | 21.16 | |||
| Sep 16, 2008 | roberts william | Officer | Option Execute | 25,000 | 8.77 | |||
| Sep 9, 2008 | brown michael s | Director | Option Execute | 5,000 | 7.66 | |||
| Aug 28, 2008 | roberts william | Officer | Acquisition (Non Open Market) | 8,106 | n/a | |||
| Aug 28, 2008 | vagelos p roy | Director | Disposition (Non Open Market) | 8,106 | n/a | |||
| Aug 22, 2008 | roberts william | Officer | Acquisition (Non Open Market) | 24,102 | n/a | |||
| Aug 22, 2008 | roberts william | Officer | Disposition (Non Open Market) | 24,102 | n/a | |||
| Aug 20, 2008 | goldstein joseph l | Director | Disposition (Non Open Market) | 2,500 | n/a | |||
| Aug 20, 2008 | roberts william | Officer | Disposition (Non Open Market) | 10,582 | 21.40 | |||
| Aug 20, 2008 | roberts william | Officer | Option Execute | 34,840 | 6.50 | |||
| Aug 11, 2008 | goldstein joseph l | Director | Acquisition (Non Open Market) | 3,000 | n/a | |||
| Aug 4, 2008 | vagelos p roy | Director | Disposition (Non Open Market) | 114,309 | n/a | |||
| Aug 4, 2008 | vagelos p roy | Director | Acquisition (Non Open Market) | 114,309 | n/a | |||
| Jul 10, 2008 | vagelos p roy | Director | Disposition (Non Open Market) | 30,705 | n/a | |||
| Jul 9, 2008 | vagelos p roy | Director | Disposition (Non Open Market) | 8,105 | n/a | |||
| Jun 13, 2008 | vagelos p roy | Director | Acquisition (Non Open Market) | 115,082 | n/a | |||
| Jun 13, 2008 | vagelos p roy | Director | Disposition (Non Open Market) | 115,082 | n/a | |||
| May 30, 2008 | shooter eric m | Director | Sell | 15,000 | 19.80 - 19.88 | |||
| May 30, 2008 | shooter eric m | Director | Option Execute | 15,000 | 9.17 | |||
| ||||||||
Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
Stock Information
| NASDAQ:REGN
$24.60 + 0.18 |
Sep 9, 2010
4:00 PM ET |
Quotes delay at least 20min., by eSignal.
